School of Pharmacy
UConn Student Research in Pharmaceutical Sciences – Summer 2021
"Summer 2021’s pharmaceutical focused research projects highlight the diverse opportunities for undergrad research for students in the School of Pharmacy and across UConn."
UConn Magazine: Underachiever No More
No one who knew Jim LaFlamme back in the ’70s would have predicted what he’s doing now.
Quarterly Recap of Pharmacy Faculty Research Grants FY 2021 Q3
The UConn School of Pharmacy congratulates the following Department of Pharmaceutical Sciences faculty and their teams for their FY 2021 Q3 research grant awards totaling $2,116,479.00:
Summer Undergraduate Researcher Mariam Zedan ’24 (PHARM)
The need for new antibiotics is crucial as drug-resistant strains of bacteria proliferate
The FDA’s Weak Drug Manufacturing Oversight is a Potentially Deadly Problem
The loss of tens of millions of COVID-19 vaccine doses due to poor manufacturing oversight underscores the value of inspections
School of Pharmacy Earns Full 8 Year Continued ACPE Accreditation
The UConn School of Pharmacy is pleased to announce that its Doctor of Pharmacy Program (Pharm.D.) has received a full eight-year accreditation by the Accreditation Council for Pharmacy Education (ACPE) Board of Directors.
The FDA’s Big Gamble on a New Alzheimer’s Drug
No one knows yet if the new drug will demonstrate significant benefits for patients
UConn Researcher Receives $2 Million from NIH to Understand Role of Non-coding RNAs in Drug Metabolism
UConn researcher Xiaobo Zhong is studying how long non-coding RNAs influence the body's ability to metabolize drugs.
‘Urban Service Talks’ (About Interprofessional Learning)
The future physicians, dentists, nurses, social workers, pharmacists, and physician assistants who take part in the Connecticut Area Health Education Center's (CT AHEC) Urban Service Track/AHEC Scholars Program are walking the walk and now, talking the talk.
Why is the FDA Funded in Part by the Companies It Regulates?
Nearly half the agency's budget now comes from 'user fees' paid by companies seeking approval for medical devices or drugs